BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 7724549)

  • 1. The 62- and 80-kDa subunits of transcription factor IIH mediate the interaction with Epstein-Barr virus nuclear protein 2.
    Tong X; Drapkin R; Reinberg D; Kieff E
    Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3259-63. PubMed ID: 7724549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Epstein-Barr virus nuclear protein 2 acidic domain forms a complex with a novel cellular coactivator that can interact with TFIIE.
    Tong X; Drapkin R; Yalamanchili R; Mosialos G; Kieff E
    Mol Cell Biol; 1995 Sep; 15(9):4735-44. PubMed ID: 7651391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1.
    Johannsen E; Koh E; Mosialos G; Tong X; Kieff E; Grossman SR
    J Virol; 1995 Jan; 69(1):253-62. PubMed ID: 7983717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional regulatory properties of Epstein-Barr virus nuclear antigen 3C are conserved in simian lymphocryptoviruses.
    Zhao B; Dalbiès-Tran R; Jiang H; Ruf IK; Sample JT; Wang F; Sample CE
    J Virol; 2003 May; 77(10):5639-48. PubMed ID: 12719556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa.
    Robertson ES; Grossman S; Johannsen E; Miller C; Lin J; Tomkinson B; Kieff E
    J Virol; 1995 May; 69(5):3108-16. PubMed ID: 7707539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and biochemical evidence that EBNA 2 interaction with a 63-kDa cellular GTG-binding protein is essential for B lymphocyte growth transformation by EBV.
    Yalamanchili R; Tong X; Grossman S; Johannsen E; Mosialos G; Kieff E
    Virology; 1994 Nov; 204(2):634-41. PubMed ID: 7941331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA-binding studies of the Epstein-Barr virus nuclear antigen 2 (EBNA-2): evidence for complex formation by latent membrane protein gene promoter-binding proteins in EBNA-2-positive cell lines.
    Sauder C; Haiss P; Grässer FA; Zimber-Strobl U; Mueller-Lantzsch N
    J Gen Virol; 1994 Nov; 75 ( Pt 11)():3067-79. PubMed ID: 7964616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational analysis of the Epstein-Barr virus nuclear antigen 2 by far-Western blotting and DNA-binding studies.
    Sauder C; Götzinger N; Schubach WH; Horvath GC; Kremmer E; Krebs A; König S; Zimber Strobl U; Mueller Lantzsch N; Grässer FA
    J Gen Virol; 1996 May; 77 ( Pt 5)():991-6. PubMed ID: 8609497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical characterization of Epstein-Barr virus nuclear antigen 3A and 3C proteins.
    Sample C; Parker B
    Virology; 1994 Dec; 205(2):534-9. PubMed ID: 7975254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Epstein-Barr virus nuclear protein 2 acidic domain can interact with TFIIB, TAF40, and RPA70 but not with TATA-binding protein.
    Tong X; Wang F; Thut CJ; Kieff E
    J Virol; 1995 Jan; 69(1):585-8. PubMed ID: 7983760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of two human transcription factor IIH (TFIIH)-related complexes: ERCC2/CAK and TFIIH.
    Reardon JT; Ge H; Gibbs E; Sancar A; Hurwitz J; Pan ZQ
    Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6482-7. PubMed ID: 8692841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The XPB subunit of repair/transcription factor TFIIH directly interacts with SUG1, a subunit of the 26S proteasome and putative transcription factor.
    Weeda G; Rossignol M; Fraser RA; Winkler GS; Vermeulen W; van 't Veer LJ; Ma L; Hoeijmakers JH; Egly JM
    Nucleic Acids Res; 1997 Jun; 25(12):2274-83. PubMed ID: 9173976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1.
    Wrightham MN; Stewart JP; Janjua NJ; Pepper SD; Sample C; Rooney CM; Arrand JR
    Virology; 1995 Apr; 208(2):521-30. PubMed ID: 7538250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein.
    Ling PD; Rawlins DR; Hayward SD
    Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9237-41. PubMed ID: 8415684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus transactivator protein, HBx, associates with the components of TFIIH and stimulates the DNA helicase activity of TFIIH.
    Qadri I; Conaway JW; Conaway RC; Schaack J; Siddiqui A
    Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10578-83. PubMed ID: 8855220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus nuclear antigen 3C is a transcriptional regulator.
    Marshall D; Sample C
    J Virol; 1995 Jun; 69(6):3624-30. PubMed ID: 7745710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and functional characterization of a complex between the acidic transactivation domain of EBNA2 and the Tfb1/p62 subunit of TFIIH.
    Chabot PR; Raiola L; Lussier-Price M; Morse T; Arseneault G; Archambault J; Omichinski JG
    PLoS Pathog; 2014 Mar; 10(3):e1004042. PubMed ID: 24675874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus nuclear protein 2A forms oligomers in vitro and in vivo through a region required for B-cell transformation.
    Tsui S; Schubach WH
    J Virol; 1994 Jul; 68(7):4287-94. PubMed ID: 8207803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modular organization of the E2F1 activation domain and its interaction with general transcription factors TBP and TFIIH.
    Pearson A; Greenblatt J
    Oncogene; 1997 Nov; 15(22):2643-58. PubMed ID: 9400991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conserved region CR2 of Epstein-Barr virus nuclear antigen leader protein is a multifunctional domain that mediates self-association as well as nuclear localization and nuclear matrix association.
    Tanaka M; Yokoyama A; Igarashi M; Matsuda G; Kato K; Kanamori M; Hirai K; Kawaguchi Y; Yamanashi Y
    J Virol; 2002 Feb; 76(3):1025-32. PubMed ID: 11773378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.